Company Filing History:
2 out of 378 
2 out of 12,160 
Years Active: 2021-2022
Title: Carmen Lobback: Innovator in Pharmaceutical Dosage Forms
Introduction
Carmen Lobback is a notable inventor based in Schöneiche, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of modified-release dosage forms. With a total of 2 patents, his work focuses on innovative solutions for treating various medical conditions.
Latest Patents
Carmen Lobback's latest patents include an orally administrable modified-release pharmaceutical dosage form. This invention relates to dosage forms comprising sodium (3S)-3-(4-chloro-3-{[(2S,3R)-2-(4-chlorophenyl)-4,4,4-trifluoro-3-methylbutanoyl]amino}phenyl)-3-cyclopropylpropanoate. The patent outlines processes for preparing these dosage forms and their applications in treating and preventing diseases, particularly cardiac, renal, and pulmonary disorders, as well as disorders of the central nervous system, fibrotic and inflammatory disorders, and metabolic disorders.
Career Highlights
Throughout his career, Carmen Lobback has worked with prominent companies in the pharmaceutical industry, including Bayer Pharma and Bayer AG. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Carmen has collaborated with notable colleagues such as Anke Stroyer and Peter Serno. These partnerships have played a crucial role in advancing his research and development efforts.
Conclusion
Carmen Lobback's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to improving healthcare solutions. His work continues to impact the treatment of various medical conditions, showcasing the importance of innovation in the pharmaceutical industry.